table of content
1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medical Product Introduction
1.2 Global Radiopharmaceuticals in Nuclear Medical Outlook 2017 VS 2022 VS 2028
1.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales in US$ Million for the Year 2017-2028
1.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume for the Year 2017-2028
1.3 United States Radiopharmaceuticals in Nuclear Medical Outlook 2017 VS 2022 VS 2028
1.3.1 United States Radiopharmaceuticals in Nuclear Medical Sales in US$ Million for the Year 2017-2028
1.3.2 United States Radiopharmaceuticals in Nuclear Medical Sales in Volume for the Year 2017-2028
1.4 Radiopharmaceuticals in Nuclear Medical Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Radiopharmaceuticals in Nuclear Medical in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Radiopharmaceuticals in Nuclear Medical Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Radiopharmaceuticals in Nuclear Medical Market Dynamics
1.5.1 Radiopharmaceuticals in Nuclear Medical Industry Trends
1.5.2 Radiopharmaceuticals in Nuclear Medical Market Drivers
1.5.3 Radiopharmaceuticals in Nuclear Medical Market Challenges
1.5.4 Radiopharmaceuticals in Nuclear Medical Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Radiopharmaceuticals in Nuclear Medical Market Segment by Type
2.1.1 Diagnostic Radiopharmaceuticals
2.1.2 Therapy Radiopharmaceuticals
2.1.3 Enriched Stable Isotopes
2.2 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type
2.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Radiopharmaceuticals in Nuclear Medical Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Radiopharmaceuticals in Nuclear Medical Market Size by Type
2.3.1 United States Radiopharmaceuticals in Nuclear Medical Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Radiopharmaceuticals in Nuclear Medical Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Radiopharmaceuticals in Nuclear Medical Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Radiopharmaceuticals in Nuclear Medical Market Segment by Application
3.1.1 Diagnostic Application
3.1.2 Therapeutic Application
3.1.3 Research
3.1.4 Pharmaceutical
3.1.5 Industrial
3.2 Global Radiopharmaceuticals in Nuclear Medical Market Size by Application
3.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Radiopharmaceuticals in Nuclear Medical Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Radiopharmaceuticals in Nuclear Medical Market Size by Application
3.3.1 United States Radiopharmaceuticals in Nuclear Medical Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Radiopharmaceuticals in Nuclear Medical Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Radiopharmaceuticals in Nuclear Medical Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Radiopharmaceuticals in Nuclear Medical Competitor Landscape by Company
4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Company
4.1.1 Top Global Radiopharmaceuticals in Nuclear Medical Manufacturers Ranked by Revenue (2021)
4.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturer (2017-2022)
4.1.3 Global Radiopharmaceuticals in Nuclear Medical Sales by Manufacturer (2017-2022)
4.1.4 Global Radiopharmaceuticals in Nuclear Medical Price by Manufacturer (2017-2022)
4.2 Global Radiopharmaceuticals in Nuclear Medical Concentration Ratio (CR)
4.2.1 Radiopharmaceuticals in Nuclear Medical Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Radiopharmaceuticals in Nuclear Medical in 2021
4.2.3 Global Radiopharmaceuticals in Nuclear Medical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution, Product Type
4.3.1 Global Radiopharmaceuticals in Nuclear Medical Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
4.3.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Radiopharmaceuticals in Nuclear Medical Market Size by Company
4.5.1 Top Radiopharmaceuticals in Nuclear Medical Players in United States, Ranked by Revenue (2021)
4.5.2 United States Radiopharmaceuticals in Nuclear Medical Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Radiopharmaceuticals in Nuclear Medical Sales by Players (2020, 2021 & 2022)
5 Global Radiopharmaceuticals in Nuclear Medical Market Size by Region
5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Radiopharmaceuticals in Nuclear Medical Market Size in Volume by Region (2017-2028)
5.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume by Region: 2017-2022
5.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales in Volume Forecast by Region (2023-2028)
5.3 Global Radiopharmaceuticals in Nuclear Medical Market Size in Value by Region (2017-2028)
5.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales in Value by Region: 2017-2022
5.3.2 Global Radiopharmaceuticals in Nuclear Medical Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2017-2028
6.1.2 North America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2017-2028
6.3.2 Europe Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2017-2028
6.4.2 Latin America Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Bracco Imaging
7.1.1 Bracco Imaging Corporation Information
7.1.2 Bracco Imaging Description and Business Overview
7.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
7.1.5 Bracco Imaging Recent Development
7.2 Cambridge Isotope Laboratories
7.2.1 Cambridge Isotope Laboratories Corporation Information
7.2.2 Cambridge Isotope Laboratories Description and Business Overview
7.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Products Offered
7.2.5 Cambridge Isotope Laboratories Recent Development
7.3 Cardinal Health
7.3.1 Cardinal Health Corporation Information
7.3.2 Cardinal Health Description and Business Overview
7.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Products Offered
7.3.5 Cardinal Health Recent Development
7.4 Medtronic
7.4.1 Medtronic Corporation Information
7.4.2 Medtronic Description and Business Overview
7.4.3 Medtronic Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Medtronic Radiopharmaceuticals in Nuclear Medical Products Offered
7.4.5 Medtronic Recent Development
7.5 Eczacibasi-Monrol
7.5.1 Eczacibasi-Monrol Corporation Information
7.5.2 Eczacibasi-Monrol Description and Business Overview
7.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Products Offered
7.5.5 Eczacibasi-Monrol Recent Development
7.6 Fujifilm Holdings Corporation
7.6.1 Fujifilm Holdings Corporation Corporation Information
7.6.2 Fujifilm Holdings Corporation Description and Business Overview
7.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
7.6.5 Fujifilm Holdings Corporation Recent Development
7.7 GE Healthcare (Subsidiary Of General Electric Company)
7.7.1 GE Healthcare (Subsidiary Of General Electric Company) Corporation Information
7.7.2 GE Healthcare (Subsidiary Of General Electric Company) Description and Business Overview
7.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Products Offered
7.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
7.8 IBA Group
7.8.1 IBA Group Corporation Information
7.8.2 IBA Group Description and Business Overview
7.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Products Offered
7.8.5 IBA Group Recent Development
7.9 Lantheus Medical Imaging
7.9.1 Lantheus Medical Imaging Corporation Information
7.9.2 Lantheus Medical Imaging Description and Business Overview
7.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
7.9.5 Lantheus Medical Imaging Recent Development
7.10 Nordion
7.10.1 Nordion Corporation Information
7.10.2 Nordion Description and Business Overview
7.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Products Offered
7.10.5 Nordion Recent Development
7.11 Ntp Radioisotopes
7.11.1 Ntp Radioisotopes Corporation Information
7.11.2 Ntp Radioisotopes Description and Business Overview
7.11.3 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ntp Radioisotopes Radiopharmaceuticals in Nuclear Medical Products Offered
7.11.5 Ntp Radioisotopes Recent Development
7.12 Siemens Healthcare
7.12.1 Siemens Healthcare Corporation Information
7.12.2 Siemens Healthcare Description and Business Overview
7.12.3 Siemens Healthcare Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Siemens Healthcare Products Offered
7.12.5 Siemens Healthcare Recent Development
7.13 Taiyo Nippon Sanso Corporation
7.13.1 Taiyo Nippon Sanso Corporation Corporation Information
7.13.2 Taiyo Nippon Sanso Corporation Description and Business Overview
7.13.3 Taiyo Nippon Sanso Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Taiyo Nippon Sanso Corporation Products Offered
7.13.5 Taiyo Nippon Sanso Corporation Recent Development
7.14 Urenco Limited
7.14.1 Urenco Limited Corporation Information
7.14.2 Urenco Limited Description and Business Overview
7.14.3 Urenco Limited Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Urenco Limited Products Offered
7.14.5 Urenco Limited Recent Development
7.15 Rotem Industries
7.15.1 Rotem Industries Corporation Information
7.15.2 Rotem Industries Description and Business Overview
7.15.3 Rotem Industries Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Rotem Industries Products Offered
7.15.5 Rotem Industries Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Radiopharmaceuticals in Nuclear Medical Industry Chain Analysis
8.2 Radiopharmaceuticals in Nuclear Medical Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Radiopharmaceuticals in Nuclear Medical Distributors
8.3 Radiopharmaceuticals in Nuclear Medical Production Mode & Process
8.4 Radiopharmaceuticals in Nuclear Medical Sales and Marketing
8.4.1 Radiopharmaceuticals in Nuclear Medical Sales Channels
8.4.2 Radiopharmaceuticals in Nuclear Medical Distributors
8.5 Radiopharmaceuticals in Nuclear Medical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
